Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05436327|
Recruitment Status : Recruiting
First Posted : June 29, 2022
Last Update Posted : August 18, 2022
|Condition or disease||Intervention/treatment||Phase|
|Cancer Aging Communication||Behavioral: Geriatric Assessment||Not Applicable|
- Establish the effectiveness of GA on patient and caregiver satisfaction and communication about age-related concerns for older patients receiving chemotherapy in community oncology practices.
- Evaluate the success of our implementation strategies on the reach, adoption, and fidelity of implementing the GA in community oncology practices.
- Identify the resources needed to implement GA and the GA-guided recommendations in community oncology practices for older patients receiving chemotherapy.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1500 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers|
|Actual Study Start Date :||May 6, 2022|
|Estimated Primary Completion Date :||January 31, 2025|
|Estimated Study Completion Date :||January 31, 2025|
Geriatric Assessment (GA)
Clinical staff undergo training in GA and are provided with facilitation and support for one year as they implement GA among older adult patients (65+) considering chemotherapy and their care partners/caregivers.
Behavioral: Geriatric Assessment
Clinical staff receive (a) training in GA and workflow management strategies (<60 minutes) at baseline, (b) monthly facilitation and technical support calls (15-30 minutes) for 12 months, and (c) a group-based quarterly call for 12 months. For 12 months, clinical staff implement GA strategies during visits with older adult (65+) patients planning to receive new chemotherapy regimen and their care partners/caregivers.
- Reach of Geriatric Assessment (GA) implementation in routine medical practice [ Time Frame: monthly over 12 months of implementation, and 6 months after implementation ]
- Reach of Geriatric Assessment (GA) implementation in routine medical practice as measured by applying the reach formula (# people served divided by potential # of people) to the following four metrics: [ Time Frame: monthly over 12 months of implementation, and 6 months after implementation ]a) patients per month who received the Geriatric Assessment (GA), b) patients per month who received Geriatric Assessment (GA)-guided recommendations, c) total patients per month age 65+, d) total patients per month who were age 65+ and receiving new chemotherapy or deciding to start chemotherapy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05436327
|Contact: Lisa Marie Lowenstein, PhD, MPH||713-792-5807||LMLowenstein@mdanderson.org|
|United States, Texas|
|MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Contact: Lisa Lowenstein, PhD, MPH 713-792-5807 LMLowenstein@mdanderson.org|
|Principal Investigator: Lisa Lowenstein, PhD, MPH|
|Principal Investigator:||Lisa Marie Lowenstein, PhD, MPH||M.D. Anderson Cancer Center|